Valeo Pharmainc (VPH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2020 | 07-2020 | 04-2020 | 01-2020 | 10-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 114 | 103 | 104 | 103 | 84 |
| Accounts receivable | -284 | 429 | -633 | -186 | 1,034 |
| Accounts payable and accrued liabilities | -503 | N/A | N/A | N/A | 275 |
| Other Working Capital | -1,447 | 248 | -384 | -656 | 1,104 |
| Other Operating Activity | 193 | -1,609 | -73 | -817 | -2,679 |
| Operating Cash Flow | $-1,927 | $-829 | $-986 | $-1,556 | $-182 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -59 | 0 | 0 | -3 | -8 |
| Purchase Sale Intangibles | -390 | -602 | -169 | -182 | -201 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 22 |
| Investing Cash Flow | $-449 | $-602 | $-169 | $-185 | $-209 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -77 |
| Debt Issued | -1,128 | 1,318 | 1,208 | 1,440 | 1,000 |
| Debt Repayment | -806 | -22 | -23 | -24 | -49 |
| Common Stock Issued | 7,244 | N/A | N/A | N/A | 1 |
| Other Financing Activity | -167 | 199 | -23 | -9 | -149 |
| Financing Cash Flow | $5,143 | $1,495 | $1,162 | $1,407 | $726 |
| Exchange Rate Effect | 1 | 4 | -7 | -1 | 0 |
| Beginning Cash Position | 68 | 0 | 0 | 335 | 0 |
| End Cash Position | 2,836 | 68 | 0 | 0 | 335 |
| Net Cash Flow | $2,767 | $64 | $7 | $-334 | $335 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,927 | -829 | -986 | -1,556 | -182 |
| Capital Expenditure | -449 | -602 | -169 | -185 | -231 |
| Free Cash Flow | -2,376 | -1,431 | -1,155 | -1,741 | -413 |